Mari Carmen Álvarez is a PhD in Biology from the University of Valencia. She has more than 15 years of experience in the management of biotechnology companies. As an entrepreneurial scientist, she has been a founding partner of Valentia Biopharma, the first biotechnological spin-off of the University of Valencia, dedicated to the search and development of drugs against rare diseases. As an R&D manager, she has participated in more than 10 international consortia, managing a multidisciplinary team. Throughout her scientific career, she has published several articles in international journals and is the author of a patent.